Collegium Pharmaceutical, Inc. (COLL)

USD 26.65

(2.54%)

Revenue Summary of Collegium Pharmaceutical, Inc.

  • Collegium Pharmaceutical, Inc.'s latest annual revenue in 2023 was 566.76 Million USD , up 22.17% from previous year.
  • Collegium Pharmaceutical, Inc.'s latest quarterly revenue in 2024 Q2 was 145.27 Million USD , up 0.24% from previous quarter.
  • Collegium Pharmaceutical, Inc. reported a annual revenue of 463.93 Million USD in annual revenue 2022, up 67.56% from previous year.
  • Collegium Pharmaceutical, Inc. reported a annual revenue of 276.86 Million USD in annual revenue 2021, down -10.69% from previous year.
  • Collegium Pharmaceutical, Inc. reported a quarterly revenue of 144.92 Million USD for 2024 Q1, down -3.22% from previous quarter.
  • Collegium Pharmaceutical, Inc. reported a quarterly revenue of 144.76 Million USD for 2023 Q1, up 11.69% from previous quarter.

Annual Revenue Chart of Collegium Pharmaceutical, Inc. (2023 - 2013)

Historical Annual Revenue of Collegium Pharmaceutical, Inc. (2023 - 2013)

Year Revenue Revenue Growth
2023 566.76 Million USD 22.17%
2022 463.93 Million USD 67.56%
2021 276.86 Million USD -10.69%
2020 310.01 Million USD 4.49%
2019 296.7 Million USD 5.81%
2018 280.41 Million USD 884.73%
2017 28.47 Million USD 1564.29%
2016 1.71 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%

Peer Revenue Comparison of Collegium Pharmaceutical, Inc.

Name Revenue Revenue Difference
Intra-Cellular Therapies, Inc. 464.37 Million USD -22.051%
PainReform Ltd. - USD -Infinity%
Alvotech 91.43 Million USD -519.865%
ANI Pharmaceuticals, Inc. 486.81 Million USD -16.423%
Aquestive Therapeutics, Inc. 50.58 Million USD -1020.469%
Journey Medical Corporation 79.18 Million USD -615.787%
Dynavax Technologies Corporation 232.28 Million USD -143.997%
Esperion Therapeutics, Inc. 116.33 Million USD -387.189%
Bright Green Corporation 401.49 Thousand USD -141065.555%
Pacira BioSciences, Inc. 674.97 Million USD 16.032%
Embecta Corp. 1.12 Billion USD 49.432%
Sunshine Biopharma, Inc. 24.09 Million USD -2252.434%
Sunshine Biopharma, Inc. 24.09 Million USD -2252.434%
SCYNEXIS, Inc. 140.14 Million USD -304.426%
Petros Pharmaceuticals, Inc. 5.82 Million USD -9634.271%
Silver Spike Investment Corp. 11.72 Million USD -4735.016%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -29289.053%
Alpha Teknova, Inc. 36.68 Million USD -1444.998%
Safety Shot Inc 202.67 Thousand USD -279550.17%
Procaps Group, S.A. 409.92 Million USD -38.263%
Cosmos Health Inc. 53.37 Million USD -961.821%
Theratechnologies Inc. 81.76 Million USD -593.174%
Harrow Health, Inc. 130.19 Million USD -335.328%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -4350.467%
Biofrontera Inc. 34.07 Million USD -1563.488%
DURECT Corporation 8.54 Million USD -6530.405%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 6.708%
Cronos Group Inc. 88.84 Million USD -537.957%
OptiNose, Inc. 70.98 Million USD -698.41%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD -28.015%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD -8601.857%
Organogenesis Holdings Inc. 433.14 Million USD -30.851%
Guardion Health Sciences, Inc. 12.24 Million USD -4527.217%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -1332.948%
Radius Health, Inc. 2.88 Billion USD 80.336%
Universe Pharmaceuticals INC 32.3 Million USD -1654.222%
ProPhase Labs, Inc. 44.38 Million USD -1176.962%
Phibro Animal Health Corporation 1.01 Billion USD 44.308%
Procaps Group S.A. 409.92 Million USD -38.263%
TherapeuticsMD, Inc. 1.3 Million USD -43430.492%
Viatris Inc. 15.42 Billion USD 96.326%
Rockwell Medical, Inc. 83.61 Million USD -577.854%
Aytu BioPharma, Inc. 81 Million USD -599.695%
SIGA Technologies, Inc. 139.91 Million USD -305.073%
Tilray Brands, Inc. 788.94 Million USD 28.161%
Lifecore Biomedical, Inc. 128.26 Million USD -341.886%
Shineco, Inc. 9.8 Million USD -5682.242%
PetIQ, Inc. 1.1 Billion USD 48.568%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -4722958.333%
Neurocrine Biosciences, Inc. 1.88 Billion USD 69.966%
Alimera Sciences, Inc. 80.75 Million USD -601.844%
Assertio Holdings, Inc. 152.06 Million USD -272.704%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Clever Leaves Holdings Inc. 17.41 Million USD -3154.102%
Cyclo Therapeutics, Inc. 1.07 Million USD -52553.694%
Avadel Pharmaceuticals plc 27.96 Million USD -1926.846%
Hempacco Co., Inc. 4.04 Million USD -13909.339%
Talphera, Inc. 651 Thousand USD -86960.983%
Alvotech 91.43 Million USD -519.865%
Eagle Pharmaceuticals, Inc. 316.61 Million USD -79.011%
Lantheus Holdings, Inc. 1.29 Billion USD 56.282%
Currenc Group, Inc. 53.25 Million USD -964.244%
Kamada Ltd. 144.75 Million USD -291.525%
Indivior PLC 1.09 Billion USD 48.146%
Evoke Pharma, Inc. 5.18 Million USD -10840.117%
Flora Growth Corp. 76.07 Million USD -645.05%
Cyclo Therapeutics, Inc. 1.07 Million USD -52553.694%
Evolus, Inc. 202.08 Million USD -180.46%
HUTCHMED (China) Limited 837.99 Million USD 32.367%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 12.047%
Akanda Corp. 2.16 Million USD -26138.581%